# Aspect Biosystems funding rounds and investors

As of 14 Oct 2026, Aspect Biosystems has raised $115M across 1 verified round on record; latest: US$115 million Series B led by Dimension, announced 8 Jan 2025.

Bioengineered cellular medicines aimed at transforming disease treatment using bioprinting technology and regenerative medicine.

Website: https://aspectbiosystems.com  
Headquarters: Vancouver, BC, Canada  
Page: https://fireround.dev/companies/aspectbiosystems.com

## Verified rounds

| Announced | Round | Amount | Lead investors | Other investors | Sources |
| --- | --- | --- | --- | --- | --- |
| 2025-01-08 | Series B | US$115 million | Dimension | InBC, Novo Nordisk, Pallasite Ventures, Pangaea Ventures, Radical Ventures, Rhino Ventures, T1D Fund | [aspectbiosystems.com](https://www.aspectbiosystems.com/news-resources/aspect-biosystems-raises-us-115-million-series-b-financing-to-advance-bioprinted-tissue-therapeutics), [businesswire.com](https://www.businesswire.com/news/home/20250108827523/en/Aspect-Biosystems-Raises-US%24115-Million-Series-B-Financing-to-Advance-Bioprinted-Tissue-Therapeutics) |

Source: Fireround (https://fireround.dev), an open-source funding feed. Each round is checked against the pages listed with it.